1. Home
  2. PTGX vs ASGN Comparison

PTGX vs ASGN Comparison

Compare PTGX & ASGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • ASGN
  • Stock Information
  • Founded
  • PTGX 2006
  • ASGN 1985
  • Country
  • PTGX United States
  • ASGN United States
  • Employees
  • PTGX N/A
  • ASGN N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • ASGN Professional Services
  • Sector
  • PTGX Health Care
  • ASGN Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • ASGN Nasdaq
  • Market Cap
  • PTGX 2.8B
  • ASGN 2.6B
  • IPO Year
  • PTGX 2016
  • ASGN 1992
  • Fundamental
  • Price
  • PTGX $42.97
  • ASGN $55.73
  • Analyst Decision
  • PTGX Strong Buy
  • ASGN Hold
  • Analyst Count
  • PTGX 8
  • ASGN 5
  • Target Price
  • PTGX $66.50
  • ASGN $74.40
  • AVG Volume (30 Days)
  • PTGX 990.2K
  • ASGN 600.0K
  • Earning Date
  • PTGX 05-06-2025
  • ASGN 04-23-2025
  • Dividend Yield
  • PTGX N/A
  • ASGN N/A
  • EPS Growth
  • PTGX N/A
  • ASGN N/A
  • EPS
  • PTGX 0.86
  • ASGN 3.52
  • Revenue
  • PTGX $207,801,000.00
  • ASGN $4,019,000,000.00
  • Revenue This Year
  • PTGX N/A
  • ASGN $0.64
  • Revenue Next Year
  • PTGX $7.13
  • ASGN $5.40
  • P/E Ratio
  • PTGX $50.68
  • ASGN $15.84
  • Revenue Growth
  • PTGX N/A
  • ASGN N/A
  • 52 Week Low
  • PTGX $24.22
  • ASGN $47.64
  • 52 Week High
  • PTGX $60.60
  • ASGN $105.67
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 43.08
  • ASGN 46.99
  • Support Level
  • PTGX $41.29
  • ASGN $49.80
  • Resistance Level
  • PTGX $46.12
  • ASGN $56.78
  • Average True Range (ATR)
  • PTGX 1.83
  • ASGN 2.07
  • MACD
  • PTGX -0.19
  • ASGN 0.78
  • Stochastic Oscillator
  • PTGX 27.81
  • ASGN 61.80

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About ASGN ASGN Incorporated

ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.

Share on Social Networks: